genetic mutation
SG P : A Sorghum Genotype Phenotype Prediction Dataset and Benchmark
Large scale field-phenotyping approaches have the potential to solve important questions about the relationship of plant genotype to plant phenotype. Computational approaches to measuring the phenotype (the observable plant features) are required to address the problem at a large scale, but machine learning approaches to extract phenotypes from sensor data have been hampered by limited access to (a) sufficiently large, organized multi-sensor datasets, (b) field trials that have a large scale and significant number of genotypes, (c) full genetic sequencing of those phenotypes, and (d) datasets sufficiently organized so that algorithm centered researchers can directly address the real biological problems. To address this, we present SGxP, a novel benchmark dataset from a large-scale field trial consisting of the complete genotype of over 300 sorghum varieties, and time sequences of imagery from several field plots growing each variety, taken with RGB and laser 3D scanner imaging. To lower the barrier to entry and facilitate further developments, we provide a set of well organized, multi-sensor imagery and corresponding genomic data. We implement baseline deep learning based phenotyping approaches to create baseline results for individual sensors and multi-sensor fusion for detecting genetic mutations with known impacts. We also provide and support an open-ended challenge by identifying thousands of genetic mutations whose phenotypic impacts are currently unknown. A web interface for machine learning researchers and practitioners to share approaches, visualizations and hypotheses supports engagement with plant biologists to further the understanding of the sorghum genotype x phenotype relationship. The full dataset, leaderboard (including baseline results) and discussion forums can be found at http://sorghumsnpbenchmark.com.
Sperm From Older Men Have More Genetic Mutations
Researchers confirmed that sperm accumulate mutations over the years, increasing the risk of transmitting diseases to offspring. All products featured on WIRED are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. Human semen not only accumulates genetic mutations with age; as the percentage of sperm carrying potentially serious mutations increases, so does the risk of developing diseases in offspring. This is according to a new study by researchers at the Sanger Institute and King's College London.
- North America > United States > New York (0.05)
- North America > United States > Utah (0.05)
- North America > United States > California (0.05)
- (2 more...)
If We May De-Presuppose: Robustly Verifying Claims through Presupposition-Free Question Decomposition
Dipta, Shubhashis Roy, Ferraro, Francis
Prior work has shown that presupposition in generated questions can introduce unverified assumptions, leading to inconsistencies in claim verification. Additionally, prompt sensitivity remains a significant challenge for large language models (LLMs), resulting in performance variance as high as 3-6%. While recent advancements have reduced this gap, our study demonstrates that prompt sensitivity remains a persistent issue. To address this, we propose a structured and robust claim verification framework that reasons through presupposition-free, decomposed questions. Extensive experiments across multiple prompts, datasets, and LLMs reveal that even state-of-the-art models remain susceptible to prompt variance and presupposition. Our method consistently mitigates these issues, achieving up to a 2-5% improvement.
- North America > United States > Maryland > Baltimore County (0.14)
- North America > United States > Maryland > Baltimore (0.14)
- Europe > Germany (0.04)
- (12 more...)
- Media (0.68)
- Leisure & Entertainment (0.68)
- Government (0.68)
SG P : A Sorghum Genotype Phenotype Prediction Dataset and Benchmark
Large scale field-phenotyping approaches have the potential to solve important questions about the relationship of plant genotype to plant phenotype. Computational approaches to measuring the phenotype (the observable plant features) are required to address the problem at a large scale, but machine learning approaches to extract phenotypes from sensor data have been hampered by limited access to (a) sufficiently large, organized multi-sensor datasets, (b) field trials that have a large scale and significant number of genotypes, (c) full genetic sequencing of those phenotypes, and (d) datasets sufficiently organized so that algorithm centered researchers can directly address the real biological problems. To address this, we present SGxP, a novel benchmark dataset from a large-scale field trial consisting of the complete genotype of over 300 sorghum varieties, and time sequences of imagery from several field plots growing each variety, taken with RGB and laser 3D scanner imaging. To lower the barrier to entry and facilitate further developments, we provide a set of well organized, multi-sensor imagery and corresponding genomic data. We implement baseline deep learning based phenotyping approaches to create baseline results for individual sensors and multi-sensor fusion for detecting genetic mutations with known impacts.
Predicting loss-of-function impact of genetic mutations: a machine learning approach
Kaur, Arshmeet, Sarmadi, Morteza
The innovation of next-generation sequencing (NGS) techniques has significantly reduced the price of genome sequencing, lowering barriers to future medical research; it is now feasible to apply genome sequencing to studies where it would have previously been cost-inefficient. Identifying damaging or pathogenic mutations in vast amounts of complex, high-dimensional genome sequencing data may be of particular interest to researchers. Thus, this paper's aims were to train machine learning models on the attributes of a genetic mutation to predict LoFtool scores (which measure a gene's intolerance to loss-of-function mutations). These attributes included, but were not limited to, the position of a mutation on a chromosome, changes in amino acids, and changes in codons caused by the mutation. Models were built using the univariate feature selection technique f-regression combined with K-nearest neighbors (KNN), Support Vector Machine (SVM), Random Sample Consensus (RANSAC), Decision Trees, Random Forest, and Extreme Gradient Boosting (XGBoost). These models were evaluated using five-fold cross-validated averages of r-squared, mean squared error, root mean squared error, mean absolute error, and explained variance. The findings of this study include the training of multiple models with testing set r-squared values of 0.97.
Artificial Intelligence Predicts Genetics of Cancerous Brain Tumors in Under 90 Seconds - Neuroscience News
Summary: New artificial intelligence technology is able to screen for genetic mutations in brain cancer tumors in less than 90 seconds. Using artificial intelligence, researchers have discovered how to screen for genetic mutations in cancerous brain tumors in under 90 seconds -- and possibly streamline the diagnosis and treatment of gliomas, a study suggests. A team of neurosurgeons and engineers at Michigan Medicine, in collaboration with investigators from New York University, University of California, San Francisco and others, developed an AI-based diagnostic screening system called DeepGlioma that uses rapid imaging to analyze tumor specimens taken during an operation and detect genetic mutations more rapidly. In a study of more than 150 patients with diffuse glioma, the most common and deadly primary brain tumor, the newly developed system identified mutations used by the World Health Organization to define molecular subgroups of the condition with an average accuracy over 90%. The results are published in Nature Medicine. "This AI-based tool has the potential to improve the access and speed of diagnosis and care of patients with deadly brain tumors," said lead author and creator of DeepGlioma Todd Hollon, M.D., a neurosurgeon at University of Michigan Health and assistant professor of neurosurgery at U-M Medical School.
- North America > United States > California > San Francisco County > San Francisco (0.58)
- North America > United States > Michigan (0.50)
- North America > United States > New York (0.26)
- Europe > Austria > Vienna (0.05)
- Health & Medicine > Therapeutic Area > Neurology (1.00)
- Health & Medicine > Therapeutic Area > Oncology > Brain Cancer (0.72)
Genetic Programming in Python: The Knapsack Problem - KDnuggets
In this article, we will look at the knapsack problem, a classic in computer science. We will explain why it is difficult to solve using traditional computational methods, and how genetic programming can help find a "good enough" solution. Afterwards, we will look at a Python implementation of just such a solution to test out for ourselves. The knapsack problem can be used to illustrate the difficulty of solving complex computational problems. In its simplest form, one is given a knapsack of a certain capacity, a set of items with their sizes and values, and asked to maximize the value of the items placed in the knapsack without exceeding the capacity.
Boffins build AI to identify genetic mutations • The Register
Machine learning techniques, such as deep learning, have proven surprisingly effective at identifying diseases like breast cancer. However, when it comes to identifying mutations at the genetic level, these models have come up short, according to researchers at the University of California San Diego (UCSD). In a paper published in the journal Nature Biotechnology this week, researchers at the university propose a new machine learning framework called DeepMosaic that uses a combination of image-based visualization and deep learning models to identify genetic mutations associated with diseases including cancer and disorders with genetic links, such as autism spectrum disorder. Using AI/ML to identify disease has been a hot topic in recent years. The problem, according to UCSD professor Joe Gleeson, is most of these models aren't well suited to identifying genetic mutations, called mosaic variants or mutations, because most of the software developed over the last two decades was trained on cancer samples. Because cancer cells divide so rapidly, they're relatively easy to spot for computer programs, he explained in an interview with The Register.
- Health & Medicine > Therapeutic Area > Oncology (1.00)
- Health & Medicine > Therapeutic Area > Genetic Disease (1.00)
- Health & Medicine > Therapeutic Area > Neurology > Autism (0.56)
Is THIS how dogs became man's best friend? Gene mutations made pups more comfortable with humans
Dogs were first domesticated around 29,000 years ago and have since become one of the most popular species of companion animals around the world. But until now, exactly why the animals became'man's best friend' has remained unclear. Now, scientists from Azabu University in Japan believe they have the answer, having discovered two key gene mutations in dogs. These mutations may have played a role in their domestication by lowering stress and making pups more comfortable interacting with humans, according to the team. Researchers from Duquesne University in Pittsburgh recently found that dogs have similar muscles in their faces to humans, allowing them to form facial expressions close to our own.
- Research Report > New Finding (0.51)
- Research Report > Experimental Study (0.32)
Image analysis based on machine learning reliably identifies haematological malignancies
Myelodysplastic syndrome (MDS) is a disease of the stem cells in the bone marrow, which disturbs the maturing and differentiation of blood cells. Annually, some 200 Finns are diagnosed with MDS, which can develop into acute leukaemia. Globally, the incidence of MDS is 4 cases per 100,000 person years. To diagnose MDS, a bone marrow sample is needed to also investigate genetic changes in bone marrow cells. The syndrome is classified into groups to determine the nature of the disorder in more detail.
- Health & Medicine > Therapeutic Area > Oncology (1.00)
- Health & Medicine > Therapeutic Area > Hematology (1.00)